You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Hematopoietic Stem Cell Transplant

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

Not yet recruiting
  • Multiple Myeloma
  • +3 more
  • (no location specified)
Oct 30, 2023

Shingles Trial (Shingrix)

Not yet recruiting
  • Shingles
  • (no location specified)
Sep 21, 2022

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

Completed
Has Results
  • Multiple Myeloma
  • Stanford, California
    Stanford University
Aug 17, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Multiple Myeloma, Tumor, Plasma Cell, Tumors by Histologic Type Trial in United States (CYNK-001)

Active, not recruiting
  • Multiple Myeloma
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +8 more
May 24, 2022

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

Multiple Sclerosis Trial (Hematopoietic stem cell transplantation)

Enrolling by invitation
  • Multiple Sclerosis
  • Hematopoietic stem cell transplantation
  • (no location specified)
Jan 26, 2021

NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

Suspended
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Jan 31, 2023

Sickle Cell Disease Trial in United States (biological, drug, genetic)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • +2 more
  • Oakland, California
  • +5 more
Sep 13, 2022

Stem Cell Trial in Houston (Enteral nutrition (EN), Standard care parenteral nutrition (PN))

Recruiting
  • Stem Cell
  • Enteral nutrition (EN)
  • Standard care parenteral nutrition (PN)
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2023

Hematopoietic Stem Cell Transplant Trial in Ann Arbor (Cardio-oncology program)

Not yet recruiting
  • Hematopoietic Stem Cell Transplant
  • Cardio-oncology program
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 6, 2023

Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell
  • fecal microbiota transplantation (FMT)
  • No fecal microbiota transplantation (FMT), routine management
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

Engraftment Syndrome Trial (Budesonide)

Not yet recruiting
  • Engraftment Syndrome
  • (no location specified)
Aug 19, 2022

Development of Liver Dysfunction in Hematopoietic Stem Cell

Not yet recruiting
  • Hematopoietic Stem Cell Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2023

    Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

    Completed
    • Mantle Cell Lymphoma
    • +6 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 18, 2022

    Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

    Not yet recruiting
    • Transplantation, Hematopoietic Stem Cell
    • Biological samples (blood and oral fluid)
    • Lyon, France
      Hôpital de la Croix Rousse - service des maladies infectieuses e
    Jul 7, 2023

    Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

    Active, not recruiting
    • Ganglioneuroblastoma
    • High Risk Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +14 more
    • Los Angeles, California
    • +9 more
    Sep 1, 2022

    ß-thalassemia Trial in Shanghai (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • Shanghai, China
      Shanghai Ruijin Hospital
    Mar 16, 2023

    Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome, Multiple Organ Dysfunction Syndrome Trial in Los Angeles,

    Completed
    • Thrombotic Microangiopathies
    • +2 more
    • Los Angeles, California
    • +2 more
    Jan 17, 2023

    Anaplastic Large Cell Lymphoma, ALK-Negative, Anaplastic Large Cell Lymphoma, ALK-Positive, Hepatosplenic T-Cell Lymphoma Trial

    Completed
    Has Results
    • Anaplastic Large Cell Lymphoma, ALK-Negative
    • +9 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
    • +7 more
    Nov 4, 2022

    Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)

    Recruiting
    • Ovarian Cancer
    • Autologous blood transfusion with haematopoietic stem cells
    • Chongqing, Chongqing, China
      Chongqing University Cancer Hospital
    May 29, 2022

    DOCK8 Deficiency Trial run by the National Cancer Institute (NCI) (Reduced-intensity hematopoietic stem cell,

    Recruiting
    • DOCK8 Deficiency
    • Reduced-intensity hematopoietic stem cell
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Multiple Myeloma Trial in Tampa (biological, procedure, drug)

    Active, not recruiting
    • Multiple Myeloma
    • Survivin Vaccine
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 7, 2022